Oxford Lane Capital Corp.
Oxford Lane Capital Corp. (OXLCP) Financial Performance & Income Statement Overview
Explore the financials of Oxford Lane Capital Corp. (OXLCP), including yearly and quarterly data on income, cash flow, and balance sheets.
Oxford Lane Capital Corp. (OXLCP) Income Statement & Financial Overview
Explore comprehensive income reports for Oxford Lane Capital Corp. OXLCP, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $223.53M | $204.20M | $157.58M | $133.07M |
| Cost of Revenue | $63.18M | $51.20M | $41.46M | $36.03M |
| Gross Profit | $0.00 | $153.002M | $116.11M | $97.04M |
| Gross Profit Ratio | $0.00 | $0.75 | $0.74 | $0.73 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $0.00 | $0.00 | -$20.18M | -$34.63M |
| Total Costs & Expenses | -$219.87M | $120.94M | $136.29M | $131.67M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $16.43M | $16.43M |
| Depreciation & Amortization | $0.00 | $0.00 | $119.86M | $115.25M |
| EBITDA | $3.66M | $83.26M | $136.29M | $131.67M |
| EBITDA Ratio | $0.02 | $0.41 | $0.86 | $0.99 |
| Operating Income | $3.66M | $83.26M | $119.86M | $115.25M |
| Operating Income Ratio | $0.02 | $0.41 | $0.76 | $0.87 |
| Other Income/Expenses (Net) | -$20.79M | -$17.67M | -$16.43M | -$16.43M |
| Income Before Tax | -$17.14M | $65.59M | $1.00 | $1.00 |
| Income Before Tax Ratio | -$0.08 | $0.32 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $1.00 | $1.00 |
| Net Income | -$17.14M | $65.59M | $217.93M | $202.18M |
| Net Income Ratio | -$0.08 | $0.32 | $1.38 | $1.52 |
| EPS | -$0.04 | $0.26 | $1.00 | $202.18M |
| Diluted EPS | -$0.04 | $0.26 | $1.00 | -$16.43M |
| Weighted Avg Shares Outstanding | $453.18M | $252.28M | $217.93M | $202.18M |
| Weighted Avg Shares Outstanding (Diluted) | $453.18M | $252.28M | $217.93M | $202.18M |
Over the past four quarters, Oxford Lane Capital Corp. demonstrated steady revenue growth, increasing from $133.07M in Q2 2023 to $223.53M in Q4 2024. Operating income reached $3.66M in Q4 2024, maintaining a consistent 2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $3.66M, reflecting operational efficiency. Net income dropped to -$17.14M, with EPS at -$0.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan